Marialessandra Contino

Author

University of Bari Aldo Moro ORCID

Also Known As

Contino M, Contino Marialess, Contino Marialessandra, M. Contino, Marialessandra Contino

139

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Bari Aldo Moro University of Turin University of Florence Istituto Tumori Bari Institute of Crystallography

About

Marialessandra Contino is an author at University of Bari Aldo Moro specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	36	1.1K
2	Natural Sciences	14	17	572
3	Engineering	5	5	133
4	Health Sciences	1	1	19
5	Social Sciences	1	1	18

Marialessandra Contino

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Antiproliferative and cytotoxic effects of some ?2 agonists and ?1 antagonists in tumour cell lines NicolaAntonio Colabufo, Francesco Berardi, Marialessandra Contino, Naunyn-Schmiedeberg s Archives of Pharmacology Cytotoxic EffectsTumour Cell LinesChemoprevention StrategyMedicinePharmacology	2004	109
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives Nicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, Bioorganic & Medicinal Chemistry Medicinal ChemistryNatural SciencesOrganic ChemistryTetrahydroisoquinoline DerivativesChemistry	2007	80
4-(Tetralin-1-yl)- and 4-(Naphthalen-1-yl)alkyl Derivatives of 1-Cyclohexylpiperazine as σ Receptor Ligands with Agonist σ<sub>2</sub> Activity Francesco Berardi, Savina Ferorelli, Carmen Abate, Journal of Medicinal Chemistry	2004	67
Structure−Affinity Relationship Study on<i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-Piperazinealkylamides, a New Class of 5-Hydroxytryptamine<sub>7</sub>Receptor Agents Marcello Leopoldo, Francesco Berardi, Nicola Antonio Colabufo, Journal of Medicinal Chemistry Molecular PharmacologyDrug TargetBiochemistryFunctional SelectivityMedicine	2004	67
Structural Modifications of <i>N</i>-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-piperazinehexanamides: Influence on Lipophilicity and 5-HT<sub>7</sub> Receptor Activity. Part III Marcello Leopoldo, Enza Lacivita, Paola De Giorgio, Journal of Medicinal Chemistry Drug TargetPart IiiPharmacotherapyPiperazine Derivatives 8-31Pharmaceutical Chemistry	2008	67
Sugar-based bactericides targeting phosphatidylethanolamine-enriched membranes Catarina Dias, João P. Pais, Rafael Nunes, Nature Communications	2018	63
F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells Giuseppe Cassano, Giuseppe Gasparre, Mauro Niso, Cell Calcium Signal TransductionSignaling PathwaySynthetic AgonistSk-n-sh CellsSigma-2 Receptor	2009	60
Sigma‐2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity Mauro Niso, Carmen Abate, Marialessandra Contino, ChemMedChem	2013	60
Is the σ<sub>2</sub> Receptor a Histone Binding Protein? Nicola Antonio Colabufo, Francesco Berardi, Carmen Abate, Journal of Medicinal Chemistry	2006	56
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators Nicola Antonio Colabufo, Francesco Berardi, Mariangela Cantore, Bioorganic & Medicinal Chemistry Potent P-gp ModulatorsBiochemistryMedicineOrganic ChemistryHeterocycle Chemistry	2008	55

Page 1